Partnerships 

Eiffel welcomes the opportunity to form partnerships with pharmaceutical companies in an effort to develop better medicines. We adopt a flexible approach to partnerships, by jointly developing work plans with partners and customising the outputs of the project according to the partner’s needs. We are also interested in evaluating opportunities for the technology in other applications.

Eiffel currently has partnerships in various fields of application:

• Particle design and formulation for inhaled insulin, asthma combination products, and inhaled corticosteroids, with MAP Pharmaceuticals Inc., a US-based company specialising in advanced pulmonary delivery products.

• Particle design and formulation of a range of proteins and peptides for transdermal delivery, with Nanotechnology Victoria, an organisation dedicated to the commercialisation of nanotechnology in Australia.

Page updated April 24, 2007